<amendment session="116" chamber="h" number="427" updated="2019-11-01T04:58:49Z">
  <amends type="h" number="3055" sequence=""/>
  <status datetime="2019-06-20">offered</status>
  <sponsor bioguide_id="B001302"/>
  <offered datetime="2019-06-20"/>
  <description>An amendment numbered 101 printed in Part B of House Report 116-119 to prevent funds from being used to finalize, implement, or enforce the draft guidance issued by the Food and Drug Administration in December of 2017 titled Drug Products Labeled as Homeopathic: Guidance for FDA Staff and Industry.</description>
  <actions>
    <action datetime="2019-06-20T12:21:03-04:00">
      <text>By unanimous consent, the Biggs amendment was withdrawn.</text>
      <reference ref="CR H4944" label="consideration"/>
    </action>
    <action datetime="2019-06-20T12:16:14-04:00">
      <text>Amendment (A041) offered by Mr. Biggs.</text>
      <reference ref="CR H4943-4944" label="consideration"/>
      <reference ref="CR H4943" label="text"/>
    </action>
    <action datetime="2019-06-20"/>
    <action datetime="2019-06-20T12:16:14-04:00">
      <text>House amendment offered/reported by: Amendment (A041) offered by Mr. Biggs.</text>
    </action>
    <action datetime="2019-06-20">
      <text>House amendment offered</text>
    </action>
  </actions>
</amendment>
